New Agar Medium for the Isolation and Testing Susceptibility of Mycobacterium Tuberculosis Against Drugs
- Technology Benefits
- The medium can be used in regular incubators (without supplemental CO2)The medium can be used at pH 6.0The medium can be used for a test with pyrazinamidThe medium is using animal serum (bovine serum for example) instead of OADCThe medium is less expensive to producePyrazinamide test can be performed more easily and faster
- Technology Application
- Isolation of M tuberculosis from patients specimensSub-cultivation of M. tuberculosis pure culturesDirect and indirect susceptibility testing.
- Detailed Technology Description
- The medium has been successfully tested to isolate M. tuberculosis and for susceptibility with pyrazinamide
- Supplementary Information
- Inventor: Heifets, Leonid | Sanchez, Tracy
Priority Number: US6579694B2
IPC Current: C12N000120 | C12Q000104 | C12Q000118
US Class: 435034 | 435391 | 435431
Assignee Applicant: National Jewish Medical and Research Centernver
Title: Agar medium for the growth of Mycobacterium tuberculosis
Usefulness: Agar medium for the growth of Mycobacterium tuberculosis
Summary: For culturing Mycobacterium tuberculosis and for testing the drug susceptibility of the culture (claimed). For susceptibility/resistance screening of the culture against a wide range of the drug.
Novelty: New medium useful for the growth of specified bacteria contains an agar base and an animal serum
- Industry
- Biomedical
- Sub Category
- DNA/Gene Engineering
- *Abstract
-
Scientists at National Jewish Health have developed a new agar medium for the isolation of M. tuberculosis from patients. The medium can also be used for testing susceptibility of M. tuberculosis against various drugs such as pyrazinamide.
- *Principal Investigator
-
Name: Leonid Heifets, Director
Department: Department of Medicine
- Country/Region
- USA
For more information, please click Here
